|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
4915548 |
| 003 |
ICU |
| 005 |
20040520122300.0 |
| 008 |
030306s2003 nyua b 001 0 eng |
| 010 |
|
|
|a 2003044717
|
| 020 |
|
|
|a 0306477440 (acid-free paper)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC271.D54
|b D533 2003
|
| 060 |
1 |
0 |
|a QU 137
|b D629 2003
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 21
|
| 245 |
0 |
0 |
|a DNA topoisomerases in cancer therapy :
|b present and future /
|c edited by Toshiwo Andoh.
|
| 260 |
|
|
|a New York :
|b Kluwer Academic/Plenum Publishers,
|c c2003.
|
| 300 |
|
|
|a xii, 202 p. :
|b ill. (some col) ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Ch. 1.
|t Reflections on an accidental discovery /
|r James C. Wang --
|g Ch. 2.
|t Mechanisms of topoisomerase I inhibition by anticancer drugs /
|r Yves Pommier, Juana Barcelo, Takahisa Furuta, Haruyuki Takemura and Olivier Sordet --
|g Ch. 3.
|t Mechanism of action of topoisomerase II-targeted anticancer drugs /
|r Kenneth D. Bromberg and Neil Osheroff --
|g Ch. 4.
|t Degradation of topoisomerase cleavable complexes /
|r Leroy F. Liu --
|g Ch. 5.
|t Yeast as a model system in the analysis of DNA topoisomerase I poisons /
|r Herve R. Jacquiau and Mary-Ann Bjornsti --
|g Ch. 6.
|t Understanding the action of drugs targeting TOP2: Yeast based systems for unraveling drug mechanisms /
|r Mobeen Malik and John L. Nitiss --
|g Ch. 7.
|t Cellular resistance to DNA topoisomerase I-targeting drugs /
|r Kae Yanase and Toshiwo Andoh --
|g Ch. 8.
|t Development of new topoisomerase I-targeting compounds as candidate anticancer drugs /
|r Yves Pommier, ZhiYong Liao and LingHua Meng --
|g Ch. 9.
|t Development of new topoisomerase II-targeting compounds as candidate anticancer drugs /
|r Toshiwo Andoh, Ken Umemura, Kae Yanase and Takao Yamori.
|
| 650 |
|
0 |
|a DNA topoisomerases
|x Inhibitors
|x Therapeutic use.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh85019497
|
| 650 |
1 |
2 |
|a DNA Topoisomerases
|x antagonists & inhibitors.
|
| 650 |
2 |
2 |
|a Drug Delivery Systems.
|
| 650 |
2 |
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
|
7 |
|a Cancer
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845327
|
| 700 |
1 |
|
|a Andoh, Toshiwo.
|0 http://id.loc.gov/authorities/names/n92802547
|1 http://viaf.org/viaf/36119207
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)51892843
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 6b9c2114-6e34-55a4-9404-7bc75662302a
|s 7e7f7978-35d0-51fc-89dd-6f46013b9e9c
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.D54 D533 2003
|l JCL
|c JCL-Sci
|i 6458478
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.D54 D533 2003
|l JCL
|c JCL-Sci
|e CRERAR
|b 63693563
|i 7493275
|
